Skip to main content
Semler Scientific, Inc. logo

Semler Scientific, Inc. — Investor Relations & Filings

Ticker · SMLR ISIN · US81684M1045 LEI · 549300ZHL16S29QTW485 US Professional, scientific and technical activities
Open in API
Filings indexed 864 across all filing types
Latest filing 2015-09-21 Director's Dealing
Country US United States of America
Listing US SMLR

About Semler Scientific, Inc.

https://www.semlerscientific.com/

Semler Scientific, Inc. is a company that develops, manufactures, and markets technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Its primary focus is on products and services that support the early detection and treatment of chronic diseases. The company's flagship product is a patented, FDA-cleared system that provides a rapid, point-of-care test to aid in the diagnosis of peripheral artery disease (PAD). In addition to its healthcare technology operations, the company has adopted a corporate strategy to acquire and hold bitcoin as its primary treasury reserve asset.

Recent filings

Filing Released Lang Actions
OWNERSHIP DOCUMENT
Director's Dealing
2015-09-21 English
OWNERSHIP DOCUMENT
Director's Dealing
2015-09-21 English
OWNERSHIP DOCUMENT
Director's Dealing
2015-09-21 English
OWNERSHIP DOCUMENT
Director's Dealing
2015-09-21 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes an amendment to extend the expiration dates of warrants, which is a material definitive agreement related to the company's capital structure. There are no financial statements or detailed financial data presented, only a description of the agreement and a reference to the exhibit. The document length is 3118 characters, which is relatively short and consistent with a regulatory announcement rather than a full financial report. This fits the category of Capital/Financing Update (CAP), as it relates to changes in financing instruments (warrants).
2015-09-21 English
PRELIMINARY PROXY STATEMENT
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Preliminary Proxy Statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. It includes detailed information about the upcoming Annual Meeting of Stockholders, including proposals to be voted on, voting instructions, and other meeting-related details. The document is clearly a proxy solicitation material intended to inform shareholders and solicit their votes for the annual meeting. It is not the actual Annual Report, nor is it a voting results announcement or a report publication announcement. The document matches the definition of Proxy Solicitation & Information Statement (PSI).
2015-09-16 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.